Company / Net Income
Thermo Fisher Scientific Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$6.7B
FY2025
5-year range
$3.7B / $7.7B
FY2021-FY2025
Trend
+5.8%
vs FY2024
Sector context
#3 of 164
Health Care
What the data says
Among 164 Health Care companies, Thermo Fisher Scientific is in the top 2% for net income. Net Income has fluctuated over the past 7 years, ranging from $3.7B in FY2021 to $7.7B in FY2023.
Based on SEC 10-K filings.
$6.7B in FY2025 with a 5-year CAGR of +1.0%. Ranks 3rd among 164 companies in Health Care.
Declined from $7.7B to $6.7B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +1.7%
- 5-Year CAGR
- +1.0%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 164This company $6.7B Sector average $467.2M
▼
+1334.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +1.0%, indicating consistent growth.
- In FY2025, net income increased 5.8% year-over-year.
- Ranks #3 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2023.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.7B | +5.8% |
| FY2024 | $6.3B | -18.0% |
| FY2023 | $7.7B | +21.2% |
| FY2022 | $6.4B | +72.4% |
| FY2021 | $3.7B | -42.0% |
| FY2020 | $6.4B | +72.4% |
| FY2019 | $3.7B | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026